UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
Oil Prices Rise as US-Iran Talks Stall, Inflation Risks Grow 
Nvidia Secures $500 Billion AI Infrastructure Push With Wall Street Giants 
Oil Prices Rise as Hormuz Reopening Remains Uncertain 
Hanwha Offers Up to $1.2 Billion for Austal US Business 
US Dollar Near Two-Month Low as Markets Await Inflation Data 
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises 
S&P 500, Nasdaq Futures Rise as Iran Risks and CPI Loom 
Oil Prices Rise as Hormuz Reopening Remains Uncertain 
China Inflation Cools in July as CPI Misses Forecast, PPI Deflation Eases 
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 
ADNOC Gas Targets Up to $4B Profit in 2026 
Yen Stabilizes After Intervention Slide as Australian Dollar Hits Eight-Week High 
US Stock Futures Flat as Iran Strait of Hormuz Demands Fuel Oil Concerns 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Moderna appointed Jorge Gomez as its new chief financial officer in April, and it was revealed that he also left his position just two days into the role. The American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, announced this week that its CFO is leaving immediately.
It is not clear if Gomez was fired or if he resigned from his post as the newly-appointed CFO at Moderna. But it was reported that his departure is related to Dentsply Sirona Inc.’s ongoing internal financial probe. The said company was Gomez’s former employer, and it recently disclosed the investigation.
“The Audit Committee is also investigating allegations that certain former and current members of senior management directed the company’s use of these incentives and other actions to achieve executive compensation targets in 2021,” New York Post quoted Dentsply as stating in a filing.
According to Fox Business, the probe is focused on the dental equipment and supplies manufacturing company’s utilization of incentives to sell its dental products to distributors. The investigation covers the sales for the third and fourth quarters of 2021.
Investigators are checking if those incentives were properly accounted for and if those sales were disclosed in periodic reports to the U.S. Securities and Exchange Commission (SEC). Since Gomez has worked in Dentsply Sirona’s financial unit, so there is a possibility that he could also be investigated; thus, he left Moderna not long after being named as its CFO.
“Today announced that its recently appointed Chief Financial Officer, Jorge Gomez, has departed the Company, effective immediately,” Moderna stated in a press release. “The announcement follows the May 10 public disclosure by Mr. Gomez's former employer, Dentsply Sirona Inc., of an ongoing internal investigation into certain matters, including financial reporting.”
Moderna also announced that Davide Meline would continue his work as the company’s CFO following Gomez’s exit. It was reported that Gomez will still get his 12 months' salary which is said to be $700,000 in total, and Consolidated Omnibus Budget Reconciliation Act (COBRA) coverage for one year. Then again, he will be forfeiting his signing bonus and eligibility for relocation reimbursements.
